Stepan(US:SCL)2026-02-23 15:02Financial Data and Key Metrics Changes - Full-year adjusted EBITDA grew by 6% to $199 million, despite a challenging macro environment and raw material inflation [5][15] - Reported net income for Q4 2025 was $5 million, up 49% year-over-year, primarily due to asset sales [9] - Consolidated adjusted EBITDA for Q4 2025 was $33.8 million, a 3% decrease from the prior year [10] - Free cash flow for 2025 was positive at $25.4 million, compared to -$0.2 million in the prior year [10][14] Business Line Data and Key Metrics Changes - Surfactants segment net sales increased to $402 million from $379 million, but organic volume declined by 3% due to weaker demand [12] - Polymers segment net sales rose to $132 million, with an 11% volume increase driven by North America and Asia [13] - Specialty Products saw modest year-over-year results due to order timing fluctuations, although medium-chain triglycerides delivered double-digit volume growth [13] Market Data and Key Metrics Changes - Global organic sales volume increased by 2% for the full year, driven by strong growth in crop productivity and oil field sectors [16] - Demand in global consumer commodity surfactants softened, impacting overall performance [5][16] Company Strategy and Development Direction - The company is focused on four strategic pillars: customer-centric innovation, diversification into higher value-end markets, operational excellence, and improving financial position through cash flow generation [17][18] - Project Catalyst aims to optimize the asset base and is expected to deliver around $100 million in pre-tax savings over the next two years [19][20] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by raw material inflation and tariffs but expressed confidence in the company's ability to deliver adjusted EBITDA growth and positive free cash flow in 2026 [22] - The company expects demand recovery in the second half of 2026, aided by anticipated interest rate cuts [40] Other Important Information - The company successfully commissioned its Pasadena sulfonation facility and divested two manufacturing plants to optimize its global footprint [4][8] - The dividend was increased for the 58th consecutive year, reflecting confidence in cash flow strength [6][7] Q&A Session Summary Question: Capacity utilization in surfactants business - Management indicated that consolidation aims to optimize cost structure and improve utilization rates, with no current losses from the sites being closed [26][28] Question: Timing of $100 million savings from Project Catalyst - Management confirmed that $60 million of the savings is expected in 2026, but inflation may offset some of these savings [29][31] Question: Impact of oleochemicals on margins - Management noted that the impact of oleochemicals worsened in Q4 but expects improvements in H2 2026 as prices stabilize [32][35] Question: Earnings growth expectations for 2026 - Management anticipates EBITDA growth in 2026, with H2 expected to perform better than H1 due to various factors including demand recovery and cost savings [38][40] Question: Demand loss due to weather - Management clarified that the majority of the $6 million demand loss in Q1 was from surfactants, with agriculture continuing to grow positively [51][52] Question: CapEx guidance for 2026 - Management indicated that the CapEx range of $105 million-$115 million reflects a new base level for sustaining CapEx, with some growth-oriented projects included [63][65] Question: Consumer behavior in personal care products - Management acknowledged that consumers are trading down in personal care, but emphasized a focus on Tier 2 and Tier 3 markets to adapt to changing demand [66][68] Question: Impact of tariffs on competitiveness - Management stated that while tariffs have had some impact, the company is well-positioned with a strong supply chain to mitigate these effects [70][71]